Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
9/12 | 6,800 USD
-0,29% |
-0,29% |
|
Baxter |
9/12 | 18,160 USD
0,00% |
0,00% |
Bayer AG |
9/12 | 36,310 EUR
+4,13% |
+4,13% |
|
Beam Therapeutics Inc |
9/12 | 26,480 USD
-2,29% |
-2,29% |
|
Becton, Dickinson And Co. |
9/12 | 188,820 USD
-0,36% |
-0,36% |
|
BeiGene Ltd |
9/12 | 318,690 USD
-2,39% |
-2,39% |
|
Bellring Brands Inc |
9/12 | 30,550 USD
+0,13% |
+0,13% |
|
Benitec Biopharma Inc |
8/12 | 13,190 USD
-2,87% |
-2,87% |
Beximco Pharmaceuticals Limited - GDR - Reg S |
8/12 | 42,000 GBX
0,00% |
0,00% |
|
BeyondSpring Inc |
8/12 | 1,980 USD
-0,50% |
-0,50% |
|
Bicycle Therapeutics Plc |
9/12 | 7,090 USD
-4,19% |
-4,19% |
|
Bio-Path Holdings Inc |
8/12 | 0,090 USD
+4,65% |
+4,65% |
|
Bio-Rad Laboratories Inc. |
8/12 | 310,700 USD
0,00% |
0,00% |
|
Bio-Rad Laboratories Inc. |
8/12 | 308,530 USD
-2,88% |
-2,88% |
|
Bio-Techne Corp |
9/12 | 58,820 USD
-2,44% |
-2,44% |
|
BioCardia Inc. |
9/12 | 1,450 USD
+1,40% |
+1,40% |
|
Biocryst Pharmaceuticals Inc. |
9/12 | 7,640 USD
-0,78% |
-0,78% |
|
Biogen |
9/12 | 175,840 USD
-2,55% |
-2,55% |
|
Biohaven Ltd |
9/12 | 10,480 USD
-0,57% |
-0,57% |
|
Biolife Solutions Inc |
8/12 | 24,950 USD
-2,00% |
-2,00% |
|
Bioline Rx Ltd |
5/12 | 3,380 USD
+3,78% |
+3,78% |
|
Biomarin Pharmaceutical Inc. |
9/12 | 53,740 USD
+0,83% |
+0,83% |
|
Biomerica Inc. |
8/12 | 2,485 USD
+6,20% |
+6,20% |
Biomerieux |
9/12 | 104,400 EUR
+0,10% |
+0,10% |
|
BiomX Inc |
8/12 | 3,260 USD
-36,94% |
-36,94% |
|
Bionano Genomics Inc |
9/12 | 1,660 USD
+1,22% |
+1,22% |
|
BioNTech SE |
9/12 | 95,850 USD
-1,47% |
-1,47% |
|
Biophytis |
9/12 | 0,081 EUR
+1,24% |
+1,24% |
|
BioRestorative Therapies Inc |
8/12 | 1,080 USD
-2,70% |
-2,70% |
BioSenic |
9/12 | 0,002 EUR
0,00% |
0,00% |
Biosyent Inc |
8/12 | 12,240 CAD
+0,49% |
+0,49% |
|
Biosynex |
8/12 | 0,492 EUR
+3,36% |
+3,36% |
|
Biotest AG |
10/06 | 40,200 EUR
-4,74% |
-4,74% |
|
Biotest AG |
10/06 | 30,400 EUR
+7,04% |
+7,04% |
|
BioVie Inc |
9/12 | 1,550 USD
-2,52% |
-2,52% |
|
BioXcel Therapeutics Inc |
9/12 | 2,130 USD
-3,18% |
-3,18% |
|
Black Diamond Therapeutics Inc |
8/12 | 2,750 USD
+3,00% |
+3,00% |
|
Bluelinea SA |
8/12 | 0,470 EUR
+2,17% |
+2,17% |
|
Boiron |
9/12 | 30,500 EUR
0,00% |
0,00% |
|
Bone Biologics Corp |
8/12 | 1,890 USD
-2,07% |
-2,07% |
|
Boston Scientific Corp. |
9/12 | 92,530 USD
-1,40% |
-1,40% |
|
Boundless Bio Inc. |
8/12 | 1,140 USD
0,00% |
0,00% |
|
BRAIN Biotech AG |
8/12 | 3,020 EUR
-0,33% |
-0,33% |
|
Brainstorm Cell Therapeutics, Inc. |
8/12 | 0,600 USD
0,00% |
0,00% |
|
Brainsway Ltd |
8/12 | 17,720 USD
+2,61% |
+2,61% |
|
BriaCell Therapeutics Corp |
8/12 | 12,550 USD
+10,18% |
+10,18% |
|
BridgeBio Pharma Inc |
8/12 | 74,240 USD
+0,81% |
+0,81% |
|
Bristol-Myers Squibb Co. |
9/12 | 50,650 USD
-1,97% |
-1,97% |
|
Bruker Corp |
8/12 | 46,000 USD
-4,23% |
-4,23% |